SCM
BNTX icon

Suvretta Capital Management’s BioNTech BNTX Stock Holding History

Suvretta Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40,970
Closed -$4.45M – 90
2023
Q3 		$4.45M Hold
40,970
– – 0.24% 54
2023
Q2 		$4.42M Hold
40,970
– – 0.24% 58
2023
Q1 		$5.1M Buy
40,970
+10,370
+34% +$1.42M 0.22% 59
2022
Q4 		$4.6M Buy
+30,600
New +$4.71M 0.19% 58

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Suvretta Capital Management's BNTX Position: Q4 2023 in Review

Suvretta Capital Management sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 40,970 shares — an estimated $4.45M sold.

Suvretta Capital Management first reported a position in BNTX in Q4 2022 and held it in 4 quarters. The position peaked at $5.1M in Q1 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Suvretta Capital Management reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Suvretta Capital Management sold 40,970 BioNTech shares in Q4 2023, an estimated $4.45M.
  • Suvretta Capital Management first reported a position in BioNTech in Q4 2022 and held it in 4 quarters.
  • Suvretta Capital Management's BioNTech position peaked at $5.1M in Q1 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Suvretta Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.